comunicacio

Researchers develop a model that predicts the COVID-19 clinical evolution at the hospital admission point

Leave a Comment / Infections of the Respiratoy Tract and in Immunocompromised Patients , Infectious disease and transplantation Program, Translational Medicine Area / By

A joint project from the UPC, the UB, the HUB, and IDIBELL studied the probability of suffering severe pneumonia, needing ventilation, or even dying during hospital admission due to COVID-19. As a result of the statistical models created, based on data from more than 5,000 patients admitted to five hospitals in different pandemic waves, they developed a web application for the early identification of potentially high-risk COVID-19 patients and the prediction of the disease course.

Researchers develop a model that predicts the COVID-19 clinical evolution at the hospital admission point Read More »

hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases

Leave a Comment / Genes, Disease and Therapy Program, Immune-inflammatory Processes and Gene Therapeutics, Translational Medicine Area / By

This support will help to develop and characterize a new immunomodulatory compound discovered by the IDIBELL group led by Dr. Josep Maria Aran.

hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases Read More »

CAC, IDIBELL and the Bellvitge University Hospital culminate the study What do you bet? about the risks of video games and gambling

Leave a Comment / Neuroscience Area, Neuroscience Program, Psychoneurobiology of Eating and Addictive Behaviours / By

The didactic material presented a year ago has been reviewed after its application as a pilot test with 3rd and 4th ESO students at the Virolai School and the Bellvitge Institute. The study concludes that educational programs prevent addictions to video games and gambling.

CAC, IDIBELL and the Bellvitge University Hospital culminate the study What do you bet? about the risks of video games and gambling Read More »

Researchers identify an effective therapeutic strategy against a subtype of melanoma currently with no treatment

Leave a Comment / Diabetes and Metabolism Program, Nutrition, metabolism and Gene Therapy , Translational Medicine Area / By

Researchers have observed that, in the absence of glucose, tumor cells become sensitive to treatment with sorafenib, a drug that was approved years ago for other indications.

Researchers identify an effective therapeutic strategy against a subtype of melanoma currently with no treatment Read More »

Symposium on Tobacco Control organized jointly with the World Health Organization

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Tobacco control research  / By

During the day, the Tobacco Control Scale was presented which describes the actions taken for tobacco control implemented in the 27 countries of the European Union plus 10 non-EU countries and which places the Spanish State in a situation very similar to that presented in the last edition in the year 2019

Symposium on Tobacco Control organized jointly with the World Health Organization Read More »

Agreement to boost and consolidate the Innovation and Health BioCluster project

Leave a Comment / Sin categorizar / By

The town councils of L’Hospitalet and Esplugues, the Bellvitge University Hospital, the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO), the Sant Joan de Déu Hospital and the University of Barcelona have signed an agreement to promote and consolidate the Innovation and Health BioCluster project.

Agreement to boost and consolidate the Innovation and Health BioCluster project Read More »

New mouse models boost personalized treatment research in endometrial cancer

Leave a Comment / Cancer, Gynaecological Cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Tumor and stromal chemoresistance  / By

To generate the new models a fresh biopsy of the original tumor was implanted into the same mouse tissue. This perfectly reproduces the original morphological and molecular characteristics, and therefore it anticipates the tumor evolution to choose the best treatment.

New mouse models boost personalized treatment research in endometrial cancer Read More »

Scroll to Top